List of Taiho Pharmaceutical patents

Patents where

Current Assignee

Name

Taiho Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10894048 Antitumor drug for intermittent administration of FGFR inhibitor	Patent 10894048 was granted and assigned to Taiho Pharmaceutical on January, 2021 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	10894048	January 19, 2021
‌ US Patent 7138140 Suplatast tosilate crystals	Patent 7138140 was granted and assigned to Taiho Pharmaceutical on November, 2006 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	7138140	November 21, 2006
‌ US Patent 10124003 Therapeutic agent for FGFR inhibitor-resistant cancer	Patent 10124003 was granted and assigned to Taiho Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	10124003	November 13, 2018
‌ US Patent 10233189 Fused pyrimidine compound or salt thereof	Patent 10233189 was granted and assigned to Taiho Pharmaceutical on March, 2019 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	10233189	March 19, 2019
‌ US Patent 11292800 Biphenyl compound or salt thereof		Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	11292800	April 5, 2022
‌ US Patent 11479563 Biphenyl compound or salt thereof	Patent 11479563 was granted and assigned to Taiho Pharmaceutical on October, 2022 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	11479563	October 25, 2022
‌ US Patent 7157459 Postoperative adjuvant chemotherapy with UFT	Patent 7157459 was granted and assigned to Taiho Pharmaceutical on January, 2007 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	7157459	January 2, 2007
‌ US Patent 11485696 Manufacturing method for high-purity cyclohexenone long-chain alcohol	Patent 11485696 was granted and assigned to Taiho Pharmaceutical on November, 2022 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	11485696	November 1, 2022
‌ US Patent 9108973 3,5-disubstituted alkynylbenzene compound and salt thereof	Patent 9108973 was granted and assigned to Taiho Pharmaceutical on August, 2015 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	9108973	August 18, 2015
‌ US Patent 7951956 Benzoimidazole compound capable of inhibiting prostaglandin D synthetase	Patent 7951956 was granted and assigned to Taiho Pharmaceutical on May, 2011 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	7951956	May 31, 2011
‌ US Patent 10155768 Fused pyrimidine compound or salt thereof	Patent 10155768 was granted and assigned to Taiho Pharmaceutical on December, 2018 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	10155768	December 18, 2018
‌ US Patent 9062035 Piperazine compound capable of inhibiting prostaglandin D synthase	Patent 9062035 was granted and assigned to Taiho Pharmaceutical on June, 2015 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	9062035	June 23, 2015
‌ US Patent 9701729 Peptide having 5 linked CTL epitopes	Patent 9701729 was granted and assigned to Taiho Pharmaceutical on July, 2017 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	9701729	July 11, 2017
‌ US Patent 8765750 Piperazine compound having a PGDS inhibitory effect	Patent 8765750 was granted and assigned to Taiho Pharmaceutical on July, 2014 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	8765750	July 1, 2014
‌ US Patent 8865714 Piperazine compound capable of inhibiting prostaglandin D synthase	Patent 8865714 was granted and assigned to Taiho Pharmaceutical on October, 2014 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	8865714	October 21, 2014
‌ US Patent 8772283 Imidazo-oxazine compound or salt thereof	Patent 8772283 was granted and assigned to Taiho Pharmaceutical on July, 2014 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	8772283	July 8, 2014
‌ US Patent 9718776 Fluorinated benzilic acid ester compound and salt thereof	Patent 9718776 was granted and assigned to Taiho Pharmaceutical on August, 2017 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	9718776	August 1, 2017
‌ US Patent 9505717 Acetic acid ester compound or salt thereof	Patent 9505717 was granted and assigned to Taiho Pharmaceutical on November, 2016 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	9505717	November 29, 2016
‌ US Patent 10174040 Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereof	Patent 10174040 was granted and assigned to Taiho Pharmaceutical on January, 2019 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	10174040	January 8, 2019
‌ US Patent RE47388 Agents for alleviating side effects	Patent RE47388 was granted and assigned to Taiho Pharmaceutical on May, 2019 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	RE47388	May 14, 2019
‌ US Patent 11236096 Fused pyrimidine compound or salt thereof	Patent 11236096 was granted and assigned to Taiho Pharmaceutical on February, 2022 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	11236096	February 1, 2022
‌ US Patent 8912181 Bicyclic compound or salt thereof	Patent 8912181 was granted and assigned to Taiho Pharmaceutical on December, 2014 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	8912181	December 16, 2014
‌ US Patent 9907792 Acetic acid ester compound or salt thereof	Patent 9907792 was granted and assigned to Taiho Pharmaceutical on March, 2018 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	9907792	March 6, 2018
‌ US Patent 10100095 Resistant mutant 90 kDa heat shock protein	Patent 10100095 was granted and assigned to Taiho Pharmaceutical on October, 2018 by the United States Patent and Trademark Office.	Taiho Pharmaceutical	Taiho Pharmaceutical	United States Patent and Trademark Office	10100095	October 16, 2018
‌ US Patent 8642572 Cytidine derivative-containing antitumor agent for continuous intravenous administration	Patent 8642572 was granted and assigned to Taiho Pharmaceutical on February, 2014 by the United States Patent and Trademark Office.		Taiho Pharmaceutical	United States Patent and Trademark Office	8642572	February 4, 2014

Results per page:

94 results

0 selected

94 results

0 selected